Benzophenone Semicarbazones as Potential alpha-glucosidase and Prolyl Endopeptidase Inhibitor: In-vitro free radical scavenging, enzyme inhibition, mechanistic, and molecular docking studies
원문 초록
$\alpha$-glucosidase and prolylendopeptidase has altered expression and activity patterns in neurological disease, type 2diabetes respectively and several cancers. Here we screened a series 1-29 benzophenone semicarbazone derivatives for in vitro free radical scavenging, alpha-glucosidase and prolylendopeptidase inhibition activities. Seven derivatives were identified as potential free radical scavengers, 14 as alpha-glucosidase, and 9 as prolylendopeptidase inhibitors. Kinetic studies on the most promising inhibitors were performed. Compounds 23, 27, 25 and 28 were found as inhibitor of alpha-glucosidase, while compound 26 inhibited both prolylendopeptidase and alpha-glucosidase. The binding modes and binding free energy of the multi targeted inhibitor 26 were predicted by molecular docking studies. These results provide insights on prolylendopeptidase and alpha-glucosidase inhibition of compound 26 for further development as therapeutic agents for neoplastic, neurological, and endocrine disorders.
함께 살펴볼 논문
공통 태그를 근거로 연결했습니다. 실제 인용 관계나 논문의 우수성을 뜻하지 않습니다.
CovDocker: Benchmarking Covalent Drug Design with Tasks, Datasets, and Solutions
PocketVina Enables Scalable and Highly Accurate Physically Valid Docking through Multi-Pocket Conditioning
PoseX: AI Defeats Physics Approaches on Protein-Ligand Cross Docking
Fast and Accurate Blind Flexible Docking
Scaling Structure Aware Virtual Screening to Billions of Molecules with SPRINT
QuickBind: A Light-Weight And Interpretable Molecular Docking Model
토론
이 논문과 연결된 포럼 글이 아직 없습니다.